Robert L. Atmar on Muck Rack

Robert L. Atmar

As seen in: Journal of Infection, Nature, MDPI, Medscape, The New England Journal of Medicine, Cell Reports Medicine, Infectious Diseases News, Journal of Virology, Texas Medical Center, CDC Featured Podcasts
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Robert L.

Contact Robert L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Norovirus Replication, Host Interactions and Vaccine Advances

|
By Robert L. Atmar
| Texas Medical Center
Nature Reviews Microbiology 10.1038/s41579-024-01144-9 Author MSS yes Humans, Norovirus, Virus Replication, Caliciviridae Infections, Viral Vaccines, Gastroenteritis, Host-Pathogen Interactions, Vaccine Development Prasad, B V Venkataram; Atmar, Robert L; Ramani, Sasirekha; et al., "Norovirus Replication, Host Interactions and Vaccine Advances" (2025). Faculty and Staff Publications. 3863. https://digitalcommons.library.tmc.edu/baylor_docs/3863
Open in Who Shared Issue with article?

Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults

|
By Geert Leroux-Roels, Robert L. Atmar, Jakob P. Cramer, Ian Escudero
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost - Nature Communications

|
By Bo Zhang, Shiyu Chen, Nadine Rouphael, Angela R. Branche, David J. Diemert, Daniel S. Graciaa, Lindsey R. Baden, Susan J Little, Richard Rupp, Craig A Magaret, David Benkeser, Antonia Netzl, Derek Smith, Angelica C. Kottkamp, Anne F. Luetkemeyer, Paul A Goepfert, Dahlene N. Fusco, Robert L. Atmar, Paul Roberts, Peter Gilbert, Dean Follmann
| Nature
Abstract Neutralizing antibody titer has been a surrogate endpoint for guiding COVID-19 vaccine approval and use, although the pandemic’s evolution and the introduction of variant-adapted vaccine boosters raise questions as to this surrogate’s contemporary performance.
Open in Who Shared Issue with article?
See all 18 licensed articles (20 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Robert L.

Contact Robert L., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified